Sage Therapeutics, Inc.
SAGEDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597553
Sage Therapeutics, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Jul 31, 2025; 192 institutions reported holding it in 13F filings for Q2 2025, worth $445.6M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Sage Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 217 | 3 | 212 | −2 |
| Shares | 50.2M | 11.0K | 49.9M | −228.7K (−0.5%) |
| Value | $2.14B | $469.0K | $1.65B | −$481.2M (−22.5%) |
3 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held Sage Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (36)
Institutions that held Sage Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
Not filed for Q1 2022 yet (3)
Institutions that held Sage Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| AlphaCentric Advisors LLC | 11,000 | $468.0K |
| Bell Investment Advisors, Inc | 35 | $1.00K |
| NEXT Financial Group, Inc | 5 | $0 |